FWP

Forward Pharma AS (FWP)

Forward Pharma AS

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FWP

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/15	06 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FWP	Forward Pharma AS
2023/01/24	20 : 08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:FWP	Forward Pharma AS
2023/01/14	06 : 43	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2023/01/06	23 : 16	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:FWP	Forward Pharma AS
2022/12/19	20 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/12/19	20 : 00	GlobeNewswire Inc.	Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market	NASDAQ:FWP	Forward Pharma AS
2022/12/07	04 : 24	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/12/07	04 : 00	GlobeNewswire Inc.	Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review	NASDAQ:FWP	Forward Pharma AS
2022/11/22	07 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/11/10	06 : 47	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/07/08	05 : 35	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/05/21	05 : 36	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/05/06	06 : 40	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/05/03	05 : 56	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2022/04/09	06 : 25	GlobeNewswire Inc.	Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021	NASDAQ:FWP	Forward Pharma AS
2022/02/15	02 : 59	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FWP	Forward Pharma AS
2021/12/27	20 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:FWP	Forward Pharma AS
2021/12/14	07 : 04	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:FWP	Forward Pharma AS
2021/12/14	07 : 02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:FWP	Forward Pharma AS
2021/10/13	06 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/09/07	20 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/09/06	23 : 21	GlobeNewswire Inc.	Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing	NASDAQ:FWP	Forward Pharma AS
2021/06/09	06 : 00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/05/28	21 : 00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/05/28	06 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/05/04	19 : 08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/04/16	06 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/04/16	06 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:FWP	Forward Pharma AS
2021/04/15	05 : 40	GlobeNewswire Inc.	Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020	NASDAQ:FWP	Forward Pharma AS
2021/04/15	05 : 20	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:FWP	Forward Pharma AS